References
- Rose, C., Mahieu, M., Hachulla, E., et al. (1997) "POEMS syndrome", Rev. Med. Interne. 18, 553–562.
- Feinberg, L., Temple, D., deMarchena, E., et al. (1990) "Soluble immune mediators in POEMS syndrome with pulmonary hyperten-sion: case report and review of literature", Crit. Rev. Oncogol. 10, 293–302.
- MiraIles, G.D., Fallon, J.R. and Talley, N.J. (1992) "Plasma cell dysrasia with polyneuropathy: the spectrum of POEM syndrome", NEJM 27, 1919–1923.
- Nakanishi, T., Sobue, I., Toyokura, et al. (1984) "The Crow—Fukase syndrome: a study of 102 cases in Japan", Neurology 34, 712–720.
- Panicker, J.N., Pavithram, K. and Thomas, M. (2000) "POEMS syndrome", JAPI 10, 1025–1026.
- Latov, N., Gross, R.B., Kastelman, J., et al. (1981) "Complement fixing antiperipheral nerve myelin antibodies in patients with inflanunatory polyneuritis and with polyneuropathy and paraprotein-emia", Neurology 31, 1530–1534.
- Mandler, RN., Kerrigan, D.P., Smart, J., et al. (1992) "Castleman's disease in POEMS syndrome with elevated interleukin-6", Cancer 11, 2697–2703.
- Kuwabara, S., Hattori, T., Shimoe, Y., et al. (1997) "Long-term melphalan—prednisolone chemotherapy for POEMS syndrome", J. Neurol. Neurosurg. Psychiatry 63, 385–387.